Drug-associated serotonin syndrome in elderly patients: a comprehensive disproportionality analysis based on the FAERS database
Drug-associated serotonin syndrome risk is elevated among elderly patients. Prompt identification and discontinuation of the causative drugs are crucial for the effective management of serotonin syndrome. In clinical practice, the risk of drug-associated serotonin syndrome should be taken into account to optimize pharmacotherapy.
Authors
- Xin Yu (ORCID: https://orcid.org/0000-0002-0269-5649)
- D. X. Lin
- Mengna Wang (ORCID: https://orcid.org/0000-0002-6903-8854)
- Xiajiong Luo
- Xiaozhi Li (ORCID: https://orcid.org/0000-0002-2135-1323)
- Xiaohua Hong (ORCID: https://orcid.org/0000-0002-5294-7445)
- Xiaoyan Li (ORCID: https://orcid.org/0000-0001-7166-0135)
- Zhikun Liang (ORCID: https://orcid.org/0000-0002-4417-6011)
- Wen-Jia Chen (ORCID: https://orcid.org/0009-0007-6049-6529)
- Hongbo Fu
- Yanqiong Zhou
Institutions
- Guiyang Medical University (CN)
- Sun Yat-sen University (CN)
- Shantou University (CN)
- Cancer Hospital of Shantou University Medical College (CN)
- Sixth Affiliated Hospital of Sun Yat-sen University (CN)
- Affiliated Hospital of Guizhou Medical University (CN)
- Second Affiliated Hospital of Shantou University Medical College (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-10-21
- DOI
- https://doi.org/10.3389/fphar.2025.1700469
- Primary Topic
- Electroconvulsive Therapy Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Sun Yat-sen University